ClinicalTrials.Veeva

Menu

E-Bike Commuting and Health in Overweight College Students

U

University of Wisconsin, River Falls

Status

Active, not recruiting

Conditions

Obesity &Amp; Overweight
Physical Inactivity
Sedentary Behaviors
Cardiometabolic Risk

Treatments

Behavioral: E-Bike Commuting

Study type

Interventional

Funder types

Other

Identifiers

NCT07114991
2025-101

Details and patient eligibility

About

This study will evaluate the effects of using a pedal-assist electric bicycle (e-bike) for commuting on physical activity, fitness, and health in overweight or obese college students. Participants will be randomly assigned to either a 12-week e-bike commuting intervention or a control group. The study will measure changes in cardiorespiratory fitness, body composition, blood biomarkers, physical activity, and psychological well-being over a 24-week period.

Full description

This randomized controlled trial investigates the effectiveness of e-bike commuting as a strategy to improve cardiometabolic health, physical activity levels, and psychological well-being in college students with a body mass index (BMI) of 25 kg/m² or higher. Eligible participants will be randomized to either a 12-week e-bike intervention group or a control group that continues usual commuting habits. Assessments will occur at baseline (Week 0), post-intervention (Week 12), and follow-up (Week 24). Each assessment will include VO₂peak testing using a graded cycle ergometer protocol, body composition assessment via BodPod, fasting fingerstick blood tests for glucose, cholesterol, and triglycerides, blood pressure and resting heart rate measurement, and self-report questionnaires evaluating motivation, stress, affect, mental health, and academic engagement. Participants will also complete a 30-minute submaximal cycling test during which affective responses will be recorded, and physical activity will be tracked over 7 days. Those assigned to the intervention group will receive a pedal-assist e-bike, helmet, and safety training and will be asked to ride at least four days per week for 12 weeks. The study aims to determine whether e-bike commuting can promote sustained physical activity and improve cardiometabolic and mental health outcomes in a population at risk for early health decline.

Enrollment

60 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 18-29 years
  • Currently enrolled undergraduate or graduate student
  • Body mass index (BMI) ≥25.0 kg/m² (classified as overweight or obese)
  • Self-report of engaging in <150 minutes per week of moderate-to-vigorous physical activity
  • Able and willing to safely ride a bicycle for commuting or transportation purposes
  • Willing to be randomized and complete all study procedures across 24 weeks Able to provide informed consent

Exclusion criteria

  • Current use of a bicycle or e-bike for commuting ≥2 times per week
  • Known cardiovascular, metabolic, or orthopedic conditions that limit physical activity or make exercise testing unsafe
  • Currently pregnant, planning pregnancy during the study period, or less than 6 months postpartum
  • Use of medications known to affect glucose metabolism, heart rate, or physical activity (e.g., beta-blockers, insulin)
  • Diagnosed severe mental health disorders that would impair study participation
  • Participation in another clinical trial or lifestyle intervention within the past 3 months
  • Inability or unwillingness to attend lab visits or comply with the intervention protocol

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Experimental Group
Experimental group
Description:
Participants in this group will receive a pedal-assist electric bicycle (e-bike), helmet, safety training, and cycling computer. They will be instructed to use the e-bike for commuting or transportation at least four days per week for 12 weeks. They will also complete assessments at baseline, Week 12, and Week 24, including fitness testing, body composition, blood testing, surveys, and activity monitoring.
Treatment:
Behavioral: E-Bike Commuting
Control Group
No Intervention group
Description:
Participants in the control group will maintain their usual commuting and physical activity habits for the 12-week intervention period. They will complete the same assessments as the intervention group at baseline, Week 12, and Week 24.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems